Astragaloside promotes the secretion of MSC-derived exosomal miR-146a-5p by regulating TRAF6/NF-κB pathway to attenuate inflammation in high glucose-impaired endothelial cells
In Vitro Cellular & Developmental Biology - Animal · 2025-01 · 61 (1) · 93-106
DOI: 10.1007/s11626-024-00984-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vitro Cellular & Developmental Biology - Animal, online erschienen am 23.10.2024. Verfasst von Jiye Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Burn and Plastic Surgery Department of Yiyang Central Hospital in Hunan Province, Yiyang, 413000, China. Hauptthemen laut MEDLINE: MicroRNAs, Exosomes, Glucose, Inflammation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Clinical Medical Technology Innovation Guidance Project of Hunan Provincial Science and Technology Department, Science and Health Joint Project of Hunan Natural Science Foundation, Scientific Research Project of Hunan Provincial Health Commission.
Abstract (Originalsprache)
This study aimed to explore the potential of using mesenchymal stem cell (MSC)-derived exosomes (MSC-Exos) pre-treated with Astragaloside IV (ASIV) to alleviate inflammation in high glucose (HG)-damaged endothelial cells. MSC-Exos were isolated from untreated MSCs and ASIV-pre-treated MSCs, and their characteristics were assessed. The expression of miR-146a-5p in MSC-Exos was determined, and it was found that ASIV treatment enhanced its expression. In order to assess the impact of highly miR-146a-5p-expressing MSC-Exos on HG-injured endothelial cells, we established a model of HG-induced inflammation using human umbilical vein endothelial cells (HUVECs). The study measured cell viability, apoptosis, tube formation, and levels of inflammatory cytokines among the different treatment groups. It was found that transferring MSC-Exos with high miR-146a-5p expression to HG-damaged HUVECs increased cell viability and tube formation ability while reducing the number of apoptotic cells. Additionally, changes in inflammatory factors indicated a reduction in the inflammatory response. Further investigation demonstrated that miR-146a-5p inhibited the expression of TNF receptor associated factor 6 (TRAF6) and phosphorylated NF-κB, which are involved in the inflammatory response. This resulted in the alleviation of inflammation in HG-damaged endothelial cells. In summary, our findings indicate that ASIV treatment stimulated the secretion of MSC-Exos that exhibited increased levels of miR-146a-5p. These exosomes, in turn, regulated the TRAF6/NF-κB pathway. As a result of this modulation, the inflammatory response in HG-damaged endothelial cells was alleviated. These findings offer a fresh approach to addressing vascular complications associated with diabetes, which could lead to novel treatment strategies in the field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Burn and Plastic Surgery Department of Yiyang Central Hospital in Hunan Province, Yiyang, 413000, China.
- College of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, 410003, China.
- Clinical Medical School of Hunan University of Chinese Medicine, Hunan Brain Hospital, Yiyang, Changsha, 410007, China.
- College of Acupuncture, Massage and Rehabilitation, Hunan University of Chinese Medicine, Changsha, 410208, China.
- College of Traditional Chinese Medicie, Hunan University of Chinese Medicine, Changsha, 410003, China.
- Department of Breast Surgery, the First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, 410003, China. kkkytd3326@126.com.
Förderung
- Clinical Medical Technology Innovation Guidance Project of Hunan Provincial Science and Technology Department
- Science and Health Joint Project of Hunan Natural Science Foundation
- Scientific Research Project of Hunan Provincial Health Commission
- The National Natural Science Foundation of China
Zitieren
APA
Chen, J., Chen, J., Li, Q., Hu, M., Zhong, X., Yu, L., Zhang, X., Huang, H., Liu, J., Huang, Z., Liu, X., & Xiong, W. (2025). Astragaloside promotes the secretion of MSC-derived exosomal miR-146a-5p by regulating TRAF6/NF-κB pathway to attenuate inflammation in high glucose-impaired endothelial cells. In Vitro Cellular & Developmental Biology - Animal, 61(1), 93-106. https://doi.org/10.1007/s11626-024-00984-2
Vancouver
Chen J, Chen J, Li Q, Hu M, Zhong X, Yu L, et al. Astragaloside promotes the secretion of MSC-derived exosomal miR-146a-5p by regulating TRAF6/NF-κB pathway to attenuate inflammation in high glucose-impaired endothelial cells. In Vitro Cellular & Developmental Biology - Animal. 2025;61(1):93-106. doi:10.1007/s11626-024-00984-2
BibTeX
@article{Chen2025,
author = {Chen, Jiye and Chen, Jiayao and Li, Qinxia and Hu, Minxia and Zhong, Xingxing and Yu, Liang and Zhang, Xi and Huang, Hongyu and Liu, Jing and Huang, Ziyi and Liu, Xinyi and Xiong, Wu},
title = {Astragaloside promotes the secretion of MSC-derived exosomal miR-146a-5p by regulating TRAF6/NF-κB pathway to attenuate inflammation in high glucose-impaired endothelial cells},
journal = {In Vitro Cellular & Developmental Biology - Animal},
year = {2025},
volume = {61},
number = {1},
pages = {93--106},
doi = {10.1007/s11626-024-00984-2}
}
EUVIMED